Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BH3120 |
Trade Name | |
Synonyms | BH-3120|BH 3120 |
Drug Descriptions |
BH3120 is a bispecific antibody targeting CD274 (PD-L1) and TNFRSF9 (4-1BB), which potentially induces antitumor immune activity (Cancer Res (2023) 83 (7_Supplement): 1799). |
DrugClasses | PD-L1/PD-1 antibody 122 TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BH3120 | BH3120 | 0 | 1 |